Immunovant, Inc. (IMVT) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Roivant Sciences Ltd. avec 113,317,007 actions. Parmi les autres détenteurs notables Health Sciences Holdings, LLC et Salzmann Peter.
Au cours des 12 derniers mois, les initiés ont effectué 30 transactions sur IMVT l'action — 5 achats (d'une valeur de $353.18M) et 21 ventes (d'une valeur de $937.25K). Les ventes d'initiés ont dépassé les achats durant cette période.
IMVT Participations des Initiés
Principal Actionnaire
Roivant Sciences Ltd.
113,317,007 actions
Achats (12 mois)
5
$353.18M valeur
Ventes (12 mois)
21
$937.25K valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Roivant Sciences Ltd. |
10 Percent Owner |
113,317,007 |
2025-12-12 |
|
| 2 |
Health Sciences Holdings, Llc |
10 Percent Owner |
10,000,000 |
2019-05-15 |
|
| 3 |
Salzmann Peter |
Chief Executive Officer |
1,178,191 |
2025-04-17 |
|
| 4 |
Wong Roderick |
Chief Executive Officer |
902,498 |
2019-12-13 |
|
| 5 |
Butchko Julia G. |
Chief Development Officer |
440,959 |
2024-08-23 |
|
| 6 |
Barnett Eva Renee |
Chief Financial Officer |
396,774 |
2025-04-17 |
|
| 7 |
Zeldin Robert K |
Chief Medical Officer |
380,325 |
2019-12-20 |
|
| 8 |
Macias William L. |
Chief Medical Officer |
357,353 |
2025-02-21 |
|
| 9 |
Levine Mark S. |
Chief Legal Officer |
319,228 |
2024-11-22 |
|
| 10 |
Geffner Michael |
Chief Medical Officer |
217,958 |
2025-10-24 |
|
| 11 |
Girao Tiago |
Chief Financial Officer |
208,388 |
2025-05-05 |
|
| 12 |
Stout Jay S |
Chief Technology Officer |
197,634 |
2026-01-23 |
|
| 13 |
Gloria Melanie |
Chief Operating Officer |
170,273 |
2026-02-27 |
|
| 14 |
Van Tuyl Christopher |
Chief Legal Officer |
147,053 |
2026-03-20 |
|
| 15 |
Middlekauff W Bradford |
General Counsel |
142,600 |
2020-05-18 |
|
| 16 |
Hughes Douglas J. |
Director |
120,773 |
2025-12-03 |
|
| 17 |
Jain Rita |
Chief Medical Officer |
117,600 |
2021-03-31 |
|
| 18 |
Elliott Michael James |
Chief Scientific Officer |
97,600 |
2021-03-23 |
|
| 19 |
Torti Frank |
Director |
93,599 |
2025-04-03 |
|
| 20 |
Fromkin Andrew J. |
Director |
85,852 |
2025-12-03 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-04-02 |
Venker Eric |
Chief Executive Officer |
Vente Informative |
1,409 |
$24.60 |
$34.66K |
| 2026-04-01 |
Venker Eric |
Chief Executive Officer |
Restitution d'Actions |
334,960 |
$25.10 |
$8.41M |
| 2026-03-18 |
Van Tuyl Christopher |
Chief Legal Officer |
Vente Informative |
2,877 |
$24.97 |
$71.84K |
| 2026-02-25 |
Gloria Melanie |
Chief Operating Officer |
Vente Informative |
942 |
$28.90 |
$27.22K |
| 2026-01-21 |
Stout Jay S |
Chief Technology Officer |
Vente Informative |
1,977 |
$26.03 |
$51.46K |
| 2026-01-07 |
Stout Jay S |
Chief Technology Officer |
Vente Informative |
55 |
$26.92 |
$1.48K |
| 2025-12-18 |
Van Tuyl Christopher |
Chief Legal Officer |
Vente Informative |
2,284 |
$27.38 |
$62.54K |
| 2025-12-12 |
Roivant Sciences Ltd. |
10 Percent Owner |
Achat Informatif |
16,666,666 |
$21.00 |
$350M |
| 2025-12-01 |
Hughes Douglas J. |
Director |
Vente Informative |
1,909 |
$23.96 |
$45.74K |
| 2025-12-01 |
Fromkin Andrew J. |
Director |
Vente Informative |
2,898 |
$23.95 |
$69.41K |
| 2025-11-20 |
Gloria Melanie |
Chief Operating Officer |
Vente Informative |
2,375 |
$23.97 |
$56.93K |
| 2025-10-22 |
Geffner Michael |
Chief Medical Officer |
Vente Informative |
2,595 |
$19.03 |
$49.38K |
| 2025-10-22 |
Stout Jay S |
Chief Technology Officer |
Vente Informative |
2,520 |
$19.03 |
$47.96K |
| 2025-10-08 |
Geffner Michael |
Chief Medical Officer |
Vente Informative |
1,272 |
$16.30 |
$20.73K |
| 2025-10-08 |
Stout Jay S |
Chief Technology Officer |
Vente Informative |
1,585 |
$16.30 |
$25.84K |
| 2025-07-28 |
Venker Eric |
Chief Executive Officer |
Attribution de RSU |
189,900 |
$16.76 |
$3.18M |
| 2025-07-23 |
Geffner Michael |
Chief Medical Officer |
Vente Informative |
2,385 |
$18.15 |
$43.29K |
| 2025-07-23 |
Stout Jay S |
Chief Technology Officer |
Vente Informative |
2,805 |
$18.15 |
$50.91K |
| 2025-07-09 |
Geffner Michael |
Chief Medical Officer |
Vente Informative |
1,160 |
$17.24 |
$20K |
| 2025-07-09 |
Stout Jay S |
Chief Technology Officer |
Vente Informative |
1,519 |
$17.24 |
$26.19K |
| 2025-05-01 |
Susman Robert Graham |
Director |
Attribution de RSU |
25,016 |
- |
- |
| 2025-05-01 |
Bauer Jake |
Director |
Attribution de RSU |
25,016 |
- |
- |
| 2025-05-01 |
Girao Tiago |
Chief Financial Officer |
Attribution de RSU |
208,388 |
- |
- |
| 2025-04-18 |
Susman Robert Graham |
Officer |
Inconnu |
- |
- |
- |
| 2025-04-18 |
Bauer Jake |
Officer |
Inconnu |
- |
- |
- |
Les autres consultent aussi
